TCTA Inhibitors
Chemical inhibitors of TCTA can disrupt its function through various methods by targeting the cytoskeletal components TCTA interacts with. For instance, Phalloidin, by binding to F-actin, stabilizes the actin filaments and can inhibit TCTA's ability to regulate cytoskeletal dynamics. Cytochalasin D and Latrunculin A disrupt actin polymerization, with the former capping the barbed ends of actin filaments and the latter sequestering actin monomers. This prevents the formation of filaments, leading to a breakdown of the cytoskeletal structure, thereby inhibiting TCTA's normal function. Jasplakinolide and Misakinolide A, conversely, promote the assembly and stabilization of actin filaments, which can perturb the dynamics of the cytoskeleton and, consequently, TCTA's function. Swinholide A further complicates the landscape by severing actin filaments, preventing their reannealing, and potentially disrupting TCTA's associated mechanisms. Chondramide also binds to actin, but its role in inhibiting actin polymerization leads to a loss of cytoskeletal organization that can inhibit TCTA's involvement with actin dynamics.
Additionally, TCTA's function can be inhibited by chemicals that affect the Golgi apparatus and microtubule dynamics. Brefeldin A and Monensin disrupt Golgi apparatus function, the former by disrupting its structure and the latter by altering pH and ion gradients essential for protein trafficking processes in which TCTA is involved. Nocodazole and Colchicine affect microtubule dynamics, with Nocodazole disrupting the polymerization of microtubules and Colchicine binding to tubulin to inhibit its polymerization into microtubules. Both of these can inhibit TCTA by impacting the microtubule dynamics that TCTA may utilize. On the other hand, Paclitaxel stabilizes microtubules and inhibits their disassembly, which affects the dynamics of microtubules necessary for TCTA's function. These chemical inhibitors, by altering the structure and dynamics of the cytoskeleton or the Golgi apparatus, can inhibit the functional performance of TCTA.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin binds to F-actin, stabilizing it and preventing its disassembly, which is crucial for maintaining cytoskeleton structure and function. As TCTA is known to be involved in the regulation of cytoskeletal dynamics, phalloidin's stabilization of F-actin could inhibit TCTA's ability to interact with and regulate the cytoskeleton. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization by capping the barbed ends of actin filaments, leading to a breakdown of the cytoskeletal structure. Since TCTA has a role in cytoskeletal organization, this disruption can inhibit the normal function of TCTA within the cell. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and sequesters them, preventing their polymerization into filaments. This inhibition of actin dynamics can indirectly inhibit TCTA's function which is dependent on actin structures. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and promotes their assembly, which can perturb the dynamics of the actin cytoskeleton. Through this alteration, TCTA's associated mechanisms within the cytoskeleton can be inhibited, as TCTA relies on the proper regulation of actin structures for its function. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Swinholide A severs actin filaments and prevents their reannealing. The resulting disruption of actin cytoskeleton dynamics could inhibit TCTA's function by altering the cytoskeletal environment it acts upon. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi apparatus, which could inhibit TCTA by interfering with its proper localization and function, as TCTA is involved in the trafficking of proteins through the Golgi. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin alters Golgi apparatus function by affecting pH and ion gradients, which are crucial for trafficking processes. TCTA's role in protein trafficking could be inhibited by the disruption of the Golgi apparatus caused by monensin. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule polymerization, which can inhibit TCTA by impacting the microtubule dynamics that TCTA may interact with or rely on for its function. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine binds to tubulin and inhibits its polymerization into microtubules, which could inhibit TCTA by disrupting microtubule-dependent processes that TCTA is involved in. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and inhibits their disassembly, affecting microtubule dynamics. This can inhibit TCTA by preventing the normal microtubule dynamics that TCTA requires for its function. | ||||||